<?xml version="1.0"?>

<document>
	<title>Cystic fibrosis and hearing loss.</title>

	<author>Forman-Franco-B.</author>
	<author>Abramson-A-L.</author>
	<author>Gorvoy-J-D.</author>
	<author>Stein-T.</author>

	<source>Arch-Otolaryngol. 1979 Jun. 105(6). P 338-42.</source>

	<abstract>The mucosal epithelium of the middle ear and Eustachian tube is in
   direct continuity with the upper respiratory tract. Since the
   otolaryngological aspects of cystic fibrosis (CF) are dominated by
   involvement of the paranasal sinuses, it might be assumed that
   children with CF would be expected to have a higher than usual
   incidence of middle ear disease. Eighty patients who were afflicted
   with CF had audiological evaluations, which consisted of hearing
   threshold levels (250 to 8,000 Hz) and speech and impedance
   audiometry. We found no greater incidence of a conductive or
   sensorineural hearing loss in patients with CF when compared with a
   normal age-adjusted population.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: co</majorsubject>
	<majorsubject>HEARING-LOSS-CONDUCTIVE: et</majorsubject>
	<majorsubject>HEARING-LOSS-PARTIAL: et</majorsubject>
	<majorsubject>HEARING-LOSS-SENSORINEURAL: et</majorsubject>

	<minorsubject>ACOUSTIC-IMPEDANCE-TESTS</minorsubject>
	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>AUDIOMETRY</minorsubject>
	<minorsubject>AUDITORY-THRESHOLD</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>EAR-OSSICLES: pp</minorsubject>
	<minorsubject>EAR-MIDDLE: pp</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>GENTAMICINS: ae</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PRESSURE</minorsubject>
	<minorsubject>STAPES: pp</minorsubject>
	<minorsubject>TOBRAMYCIN: ae</minorsubject>
	<minorsubject>TYMPANIC-MEMBRANE: pp</minorsubject>

	<reference>001   KULCZYCKI LL          CLIN PEDIATR                     9   390 970</reference>
	<reference>002   ANON                  TRANS AM ACAD OPHTHALMOL OTOL   63   236 959</reference>
	<reference>003   JERGER J              ARCH OTOLARYNGOL                93   111 971</reference>
	<reference>004   TAYLOR BW             ARCH DIS CHILD                  49   133 974</reference>
	<reference>005   GOODMAN A             ASHA                             7   262 965</reference>
	<reference>006   RULON JT              ARCH OTOLARYNGOL                78   192 963</reference>
	<reference>007   CRIFO S               PRACT OTORHINOLARYNGOL          33   394 971</reference>
	<reference>008   KULCZYCKI LL          ARCH OTOLARYNGOL                92    54 970</reference>
	<reference>009   ROBINSON CG           CAN MED ASSOC J                 97  1199 967</reference>
	<reference>010   EAGLES E              LARYNGOSCOPE                    73    12 963</reference>
	<reference>011   SIEGEL J              ARCH OTOLARYNGOL                92   523 970</reference>
	<reference>012   FORCUCCI RA           ARCH OTOLARYNGOL                96   361 972</reference>
	<reference>013   FRITZE W              Z KINDERHEILK                  114   111 973</reference>
	<reference>014   WATSON TJ             PROC R SOC MED                  62   455 969</reference>
	<reference>015   BROOKS DN             INT AUDIOL                       8   563 969</reference>
	<reference>016   NEELY JG              TRANS AM ACAD OPHTHALMOL OTOL   76   313 972</reference>

	<citation>1   CRIFO S               INT J PEDIATR OTORHINOLARYNGO    2   251 980</citation>
	<citation>2   FRASER GL             DRUG INTEL CLIN PHARM           19   757 985</citation>
	<citation>3   DAVID TJ              J ROY SOC MED                   79    23 986</citation>

</document>
